When is hemodialysis (HD) recommended for severe metabolic acidosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hemodialysis for Severe Metabolic Acidosis

Hemodialysis is indicated for severe metabolic acidosis when pH falls below 7.20 in the absence of other indications, or when severe acidosis persists despite standard medical therapy including bicarbonate supplementation and optimization of dialysate bicarbonate concentration. 1

Primary Indications for Dialysis in Severe Metabolic Acidosis

Absolute indications for emergent hemodialysis include:

  • Severe acidemia with pH <7.20 despite maximal medical management, as this threshold represents life-threatening acid-base disturbance 1
  • Persistent severe metabolic acidosis unresponsive to bicarbonate therapy in the setting of acute kidney injury or chronic kidney disease 1
  • Metabolic acidosis accompanied by life-threatening hyperkalemia (>6.0 mmol/L), as these conditions frequently coexist and both require urgent dialytic correction 2
  • Acidosis with volume overload unresponsive to diuretics, particularly when accompanied by pulmonary edema 1
  • Uremic symptoms (encephalopathy, pericarditis) occurring with metabolic acidosis, as these represent absolute indications for immediate dialysis 2

Context-Specific Scenarios

Poisoning and Toxic Ingestions

  • Salicylate poisoning with pH <7.20 warrants extracorporeal treatment regardless of salicylate concentration, with intermittent hemodialysis being the preferred modality 1
  • Ethylene glycol poisoning with severe acidemia (pH <6.60 or bicarbonate <2 mmol/L) requires immediate hemodialysis, as survival has been documented even with extreme acid-base abnormalities when dialysis is initiated promptly 1
  • Acidemia correction occurs rapidly with high-efficiency hemodialysis in toxic ingestions, typically within 4 hours 1

Tumor Lysis Syndrome

  • Severe metabolic acidosis in tumor lysis syndrome mandates renal replacement therapy, particularly when accompanied by persistent hyperkalemia and hyperphosphatemia 1, 3, 4
  • Frequent (daily) dialysis is recommended due to continuous release of metabolites and ongoing acid production from tumor cell lysis 1, 4

Chronic Dialysis Patients

  • For maintenance hemodialysis patients, predialysis serum bicarbonate should be maintained at ≥22 mmol/L through optimization of dialysate bicarbonate concentration (typically 38 mmol/L) and oral bicarbonate supplementation (25-50 mEq/day) 1
  • Persistent metabolic acidosis (bicarbonate <22 mmol/L) occurs in up to 73% of hemodialysis patients and requires prescription modification 5

Dialysis Modality Selection

Intermittent hemodialysis (IHD) is the preferred initial modality for severe metabolic acidosis requiring rapid correction 2:

  • IHD provides superior efficiency for acid removal and electrolyte correction compared to peritoneal dialysis 1
  • High-flux dialyzers with bicarbonate dialysate (38 mmol/L) achieve rapid pH normalization 1

Continuous renal replacement therapy (CRRT) should be reserved for:

  • Hemodynamically unstable patients who cannot tolerate intermittent hemodialysis 1, 2
  • Patients requiring continuous acid-base control with ongoing acid production 1, 2
  • CRRT provides better hemodynamic stability but slower acid correction than IHD 1

Peritoneal dialysis has limited utility in severe metabolic acidosis due to lower efficiency for solute and acid removal, and should only be used when other modalities are unavailable 1

Critical Pitfalls and Caveats

Bicarbonate Buffer Selection

  • Both lactate and bicarbonate buffers can correct metabolic acidosis in most CRRT patients, but bicarbonate is strongly preferred in patients with lactic acidosis or liver failure, as lactate-based solutions can worsen acidosis in these populations 1
  • Citrate anticoagulation during dialysis can cause both metabolic alkalosis and metabolic acidosis depending on citrate metabolism, requiring close monitoring of systemic acid-base balance 1

Monitoring Requirements

  • Predialysis serum bicarbonate should be measured monthly in maintenance dialysis patients to detect persistent acidosis 1
  • In acute settings with severe acidosis, arterial blood gas monitoring should guide therapy intensity 1
  • Post-dialysis bicarbonate levels should be checked, as 41% of patients may remain acidotic even after hemodialysis treatment 5

Dialysate Composition

  • Sorbent system hemodialysis with bicarbonate regeneration can paradoxically cause or worsen metabolic acidosis due to variable and often low dialysate bicarbonate concentrations (mean 16.5 mEq/L), and should be avoided 6
  • Standard single-pass hemodialysis with fixed bicarbonate dialysate is safer and more predictable 6

Associated Electrolyte Disturbances

  • Do not routinely supplement calcium in patients with concurrent hyperphosphatemia and hypocalcemia, as this worsens calcium-phosphate precipitation in tissues 2
  • Only symptomatic hypocalcemia (tetany, seizures) requires cautious calcium gluconate administration 2
  • Hyperkalemia frequently accompanies severe metabolic acidosis and may be the primary indication for urgent dialysis 2, 7

Protein Metabolism Considerations

  • Uncorrected metabolic acidosis increases protein degradation, branched-chain amino acid oxidation, and decreases albumin synthesis 1
  • Higher protein nitrogen appearance (protein breakdown) independently predicts metabolic acidosis in dialysis patients 7
  • Correction of acidosis improves nutritional parameters including serum albumin, body weight, and mid-arm circumference 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hemodialysis for Life-Threatening Conditions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Constipation in Patients with Tumor Lysis Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Radiotherapy-Induced Tumor Lysis Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

An unsuspected cause for metabolic acidosis in chronic renal failure: sorbent system hemodialysis.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 1985

Research

Determinants of metabolic acidosis among hemodialysis patients.

Hemodialysis international. International Symposium on Home Hemodialysis, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.